FXR (NR1H4) modulating compounds
PA Blomgren, KS Currie, J Farand, C Gege… - US Patent …, 2019 - Google Patents
The present disclosure relates generally to compounds which bind to the NR1H4 receptor
(FXR) and act as agonists of FXR. The disclosure further relates to the use of the compounds …
(FXR) and act as agonists of FXR. The disclosure further relates to the use of the compounds …
FXR (NR1H4) modulating compounds
PA Blomgren, KS Currie, C Gege, JE Kropf… - US Patent …, 2019 - Google Patents
The present disclosure relates generally to compounds which bind to the NR1H4 receptor
(FXR) and act as agonists of FXR. The disclosure further relates to the use of the compounds …
(FXR) and act as agonists of FXR. The disclosure further relates to the use of the compounds …
FXR (NR1H4) binding and activity modulating compounds
O Kinzel, C Steeneck, C Kremoser - US Patent 10,220,027, 2019 - Google Patents
The present invention relates to compounds which bind to the NR1H4 receptor (FXR) and
act as agonists of FXR. The invention further relates to the use of the compounds for the …
act as agonists of FXR. The invention further relates to the use of the compounds for the …
FXR (NR1H4) binding and activity modulating compounds
O Kinzel, C Steeneck, C Kremoser - US Patent 10,485,795, 2019 - Google Patents
The present invention relates to compounds which bind to the NR1H4 receptor (FXR) and
act as agonists of FXR. The invention further relates to the use of the compounds for the …
act as agonists of FXR. The invention further relates to the use of the compounds for the …
FXR (NR1H4) modulating compounds
PA Blomgren, J Xu - US Patent 10,981,881, 2021 - Google Patents
The present disclosure relates generally to compounds which bind to the NR1H4 receptor
(FXR) and act as agonists of FXR. The disclosure further relates to the use of the compounds …
(FXR) and act as agonists of FXR. The disclosure further relates to the use of the compounds …
FXR (NR1H4) modulating compounds
PA Blomgren, KS Currie, MM Frick… - US Patent …, 2022 - Google Patents
2008/0032990 Al 2008/0114044 Al 2008/0182837 A1 2008/0194634 A1 2008/0207910 A1
2009/0074717 A1 2009/0076103 A1 2009/0105251 A1 2009/0143451 A1 2009/0197880 …
2009/0074717 A1 2009/0076103 A1 2009/0105251 A1 2009/0143451 A1 2009/0197880 …
3, 5-diaminopyrazole kinase inhibitors
ED Raaum, GT Potter, TW Ly - US Patent 8,916,555, 2014 - Google Patents
2013-07-16 Assigned to AXIKIN PHARMACEUTICALS, INC. reassignment AXIKIN
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
Pharmaceutically acceptable salts of 3, 5-diaminopyrazole kinase inhibitors
TW Ly, ED Raaum - US Patent 9,540,351, 2017 - Google Patents
Provided herein are pharmaceutically acceptable salts of 3, 5-diaminopyrazoles, for
example, pharmaceutically acceptable salts of compounds of Formula IA, that are useful for …
example, pharmaceutically acceptable salts of compounds of Formula IA, that are useful for …
3, 5-diaminopyrazole kinase inhibitors
ED Raaum, GT Potter, TW Ly - US Patent 9,382,237, 2016 - Google Patents
2015-08-05 Assigned to AXIKIN PHARMACEUTICALS, INC. reassignment AXIKIN
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
3, 5-diaminopyrazole kinase inhibitors
ED Raaum, GT Potter, TW Ly - US Patent 9,365,556, 2016 - Google Patents
A6 IK3I/427(2006.01) A6 IK3I/4439(2006.01)(57) ABSTRACT A6 IK3 L/454(2006.01) A6
IK3I/496(2006.01) Provided herein are 3, 5-diaminopyrazoles, for example, CO A6 …
IK3I/496(2006.01) Provided herein are 3, 5-diaminopyrazoles, for example, CO A6 …